Exiqon

About:

Exiqon operates in two business areas, Life Sciences and Diagnostics.

Website: http://www.exiqon.com/

Twitter/X: exiqon_science

Top Investors: Danske Bank, Noble Resources, Teknoinvest, SLS Venture, LD Pensions

Description:

Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.

Total Funding Amount:

$20M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vedbæk, Hovedstaden, Denmark

Founded Date:

1995-01-01

Founders:

Troels Koch

Number of Employees:

51-100

Last Funding Date:

2005-06-03

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai